Hesperidin protects brain and sciatic nerve tissues against cisplatin-induced oxidative, histological and electromyographical side effects in rats

Toxicology and Industrial Health

Volumn 31, Issue 9, 2015, Pages 841-851

  Kamisli, Suat ^a   Ciftci, Osman ^a   Kaya, Kursat ^a   Cetin, Asli ^a   Kamisli, Ozden ^a   Ozcan, Cemal ^a  

^a INONU UNIVERSITY   (Turkey)

Author keywords

Cisplatin; electromyography; hesperidin; neurotoxic effect; oxidative damage

Indexed keywords

ANTIOXIDANT; CATALASE; CISPLATIN; GLUTATHIONE PEROXIDASE; HESPERIDIN; PROTECTIVE AGENT; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; CASPASE 3; COPPER ZINC SUPEROXIDE DISMUTASE; GLUTATHIONE;

ANIMAL; APOPTOSIS; BRAIN; DRUG EFFECTS; LIPID PEROXIDATION; MALE; METABOLISM; OXIDATIVE STRESS; RAT; SCIATIC NERVE; SPRAGUE DAWLEY RAT; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN CORTEX; BRAIN PROTECTION; CELL INFILTRATION; CEREBELLUM CORTEX; CONTROLLED STUDY; CYTOPLASM; ELECTROMYOGRAPHY; ENZYME ACTIVITY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; NERVE CELL; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PURKINJE CELL;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; BRAIN; CATALASE; CISPLATIN; GLUTATHIONE PEROXIDASE; HESPERIDIN; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; PROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; SCIATIC NERVE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 84940772214     PISSN: 07482337     EISSN: 14770393     Source Type: Journal    
DOI: 10.1177/0748233713483192     Document Type: Article

References (32)

1. Abou-Elghait A, El-Gamal DA, Abdel-Sameea AR, Mohamed AA (2010) Effect of cisplatin on the cerebellar cortex and spinal cord of adult male albino rat and the possible role of vitamin E: light and electron microscopic study. Egyptian Journal of Histology 33(2): 202–212.
2. Acar A, Akil E, Alp H, Evliyaoglu O, Kibrisli E, Inal A et al. (2012) Oxidative damage is ameliorated by curcumin treatment in brain and sciatic nerve of diabetic rats. International Journal of Neuroscience 122(7): 367–372.
3. Aebi H (1974) Catalase. In: Bergmeyer HU (ed.) Methods of Enzymatic Analysis. New York, NY: Academic Press, pp. 673–677.
4. Barabas K, Milner R, Lurie D, Adin C (2008) Cisplatin: a review of toxicities and therapeutic applications. Veterinary and Comparative Oncology 6(1): 1–18.
5. Beytur A, Ciftci O, Oguz F, Oguzturk H, Yilmaz F (2012) Montelukast attenuates side effects of cisplatin including testicular, spermatological, and hormonal damage in male rats. Cancer Chemotheraphy and Pharmacology 69(1): 207–213.
6. Carozzi V, Chiorazzi A, Canta A, Oggioni N, Gilardini A, Rodriguez-Menendez V et al. (2009) Effect of the chronic combined administration of cisplatin and paclitaxel in a rat model of peripheral neurotoxicity. European Journal of Cancer 45(4): 656–665.
7. Carozzi VA, Marmiroli P, Cavaletti G (2010) The role of oxidative stress and anti-oxidant treatment in platinum-induced peripheral neurotoxicity. Current Cancer Drug Targets 10(7): 670–682.
8. Choi EJ, Ahn WS (2008) Neuroprotective effects of chronic hesperetin administration in mice. Archives of Pharmacal Research 31(11): 1457–1462.
9. Hartmann JT, Kollmannsberger C, Kanz L, Bokemeyer C (1999) Platinum organ toxicity and possible prevention in patients with testicular cancer. International Journal of Cancer 83(6): 866–869.
10. Hwang SL, Shih PH, Yen GC (2012) Neuroprotective effects of citrus flavonoids. Journal of Agricultural Food Chemistry 60(4): 877–885.
11. Hwang SL, Yen GC (2008) Neuroprotective effects of the citrus flavanones against H2O2-induced cytotoxicity in PC12 cells. Journal of Agricultural and Food Chemistry 56(3): 859–864.
12. Kalender AM, Dogan A, Bakan V, Yildiz H, Gokalp MA, Kalender M (2009) Effect of zofenopril on regeneration of sciatic nerve crush injury in a rat model. Journal of Brachial Plexus and Peripheral Nerve Injury 4: 6.
13. Kirchmair R, Walter DH, Ii M, Rittig K, Tietz AB, Murayama T et al. (2005) Antiangiogenesis mediates cisplatin-induced peripheral neuropathy: attenuation or reversal by local vascular endothelial growth factor gene therapy without augmenting tumor growth. Circulation 111(20): 2662–2670.
14. Korte N, Schenk HC, Grothe C, Tipold A, Haastert-Talini K (2011) Evaluation of periodic electrodiagnostic measurements to monitor motor recovery after different peripheral nerve lesions in the rat. Muscle and Nerve 44(1): 63–73.
15. Krarup-Hansen A, Fugleholm K, Helweg-Larsen S, Hauge EN, Schmalbruch H, Trojaborg W et al. (1993) Examination of distal involvement in cisplatin-induced neuropathy in man. An electrophysiological and histological study with particular reference to touch receptor function. Brain 116(Pt 5): 1017–1041.
16. Lowry OH, Rosebrough NJ, Farr AL, Randall RI (1951) Protein measurement with folin phenol reagent. Journal of Biological Chemistry 193: 265–275.
17. Menze ET, Tadros MG, Abdel-Tawab AM, Khalifa AE (2012) Potential neuroprotective effects of hesperidin on 3-nitropropionic acid-induced neurotoxicity in rats. Neurotoxicology 33(5): 1265–1275.
18. Olas B, Wachowicz B (2004) Resveratrol reduces oxidative stress induced by platinum compounds in blood platelets. General Physiologya nd Biophysics 23(3): 315–326.
19. Orhan B, Yalcin S, Nurlu G, Zeybek D, Muftuoglu S (2004) Erythropoietin against cisplatin-induced peripheral neurotoxicity in rats. Medical Oncology 21(2): 197–203.
20. Paglia DE, Valentine WN (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. Journal of Laboratory and Clinical Medicine 70: 158–169.
21. Qu J, Li X, Wang J, Mi W, Xie K, Qiu J (2012) Inhalation of hydrogen gas attenuates cisplatin-induced ototoxicity via reducing oxidative stress. International Journal of Pediatric Otorhinolaryngology 76(1): 111–115.
22. Rodriguez-Menendez V, Gilardini A, Bossi M, Canta A, Oggioni N, Carozzi V et al. (2008) Valproate protective effects on cisplatin-induced peripheral neuropathy: an in vitro and in vivo study. Anticancer Research 28(1A): 335–342.
23. Rosenberg B (1978) Platinum complexes fort he treatment of cancer. Interdisciplinary Science Revivews 3: 134–137.
24. Rybak LP, Husain K, Morris C, Whitworth C, Somani S (2000) Effect of protective agents against cisplatin ototoxicity. American Journal of Otolaryngology 21(4): 513–520.
25. Sedlak J, Lindsay RH (1968) Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman’s reagent. Analytical Biochemistry 25: 192–205.
26. Shagirtha K, Pari L (2011) Hesperetin, a citrus flavonone, protects potentially cadmium induced oxidative testicular dysfunction in rats. Ecotoxicology and Environmental Safety 74(7): 2105–2111.
27. Stålberg E, Erdem H (2002) Quantitative motor unit potential analysis in routine. Electromyography and Clinical Neurophysiology 42(7): 433–442.
28. Sun Y, Oberley LW, Li YA (1988) Simple method for clinical assay of superoxide dismutase. Clinical Chemistry 34: 497–500.
29. Tuncer S, Dalkilic N, Akif Dunbar M, Keles B (2010) Comparative effects of α lipoic acid and melatonin on cisplatin-induced neurotoxicity. International Journal of Neuroscience 120(10): 655–663.
30. Yagi K (1998) Simple assay for the level of total lipid peroxides in serum or plasma. Methods in Molecular Biology 108: 101–106.
31. Yüce A, Ateşşahin A, Ceribaşi AO, Aksakal M (2007) Ellagic acid prevents cisplatin-induced oxidative stress in liver and heart tissue of rats. Basic and Clinical Pharmacology and Toxicology 101(5): 345–349.
32. Youdim KA, Dobbie MS, Kuhnle G, Proteggente AR, Abbott NJ, Rice-Evans C (2003) Interaction between flavonoids and the blood–brain barrier: in vitro studies. Journal of Neurochemistry 85(1): 180–192.